Huntington National Bank’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$975 Hold
13
﹤0.01% 2564
2026
Q1
$733 Hold
13
﹤0.01% 2403
2025
Q4
$1.04K Buy
13
+11
+550% +$739 ﹤0.01% 2277
2025
Q3
$97 Sell
2
-3
-60% -$186 ﹤0.01% 2627
2025
Q2
$373 Sell
5
-40
-89% -$2.65K ﹤0.01% 2493
2025
Q1
$2.86K Buy
45
+18
+67% +$1.22K ﹤0.01% 2141
2024
Q4
$2.11K Buy
27
+5
+23% +$402 ﹤0.01% 2235
2024
Q3
$1.77K Sell
22
-8
-27% -$646 ﹤0.01% 2264
2024
Q2
$2.48K Buy
30
+10
+50% +$880 ﹤0.01% 2105
2024
Q1
$1.71K Sell
20
-10
-33% -$785 ﹤0.01% 2176
2023
Q4
$2.56K Buy
30
+16
+114% +$1.38K ﹤0.01% 2030
2023
Q3
$1.25K Buy
+14
New +$1.25K ﹤0.01% 2177
2020
Q3
Sell
-252
Closed -$23K 1602
2020
Q2
$23K Buy
252
+77
+44% +$7.78K ﹤0.01% 980
2020
Q1
$17K Buy
+175
New +$19K ﹤0.01% 1077
2016
Q2
Sell
-153
Closed -$7K 1574
2016
Q1
$7K Sell
153
-35
-19% -$1.13K ﹤0.01% 1517
2015
Q4
$6K Buy
188
+35
+23% +$1.14K ﹤0.01% 1429
2015
Q3
$5K Hold
153
﹤0.01% 1520
2015
Q2
$6K Hold
153
﹤0.01% 1572
2015
Q1
$7K Buy
153
+78
+104% +$3.26K ﹤0.01% 1527
2014
Q4
$3K Buy
+75
New +$2.75K ﹤0.01% 1594

Other funds holding HAE

Huntington National Bank's HAE Position: Q2 2026 in Review

Huntington National Bank held its Haemonetics (HAE) position steady in Q2 2026 at 13 shares worth $975. The position accounts for ﹤0.01% of the portfolio, ranked #2564.

Huntington National Bank first reported a position in HAE in Q4 2014 and has held it in 20 quarters since. The position peaked at $23K in Q2 2020. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Huntington National Bank held 13 shares of Haemonetics worth $975 as of Q2 2026.
  • Huntington National Bank left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2564 holding.
  • Huntington National Bank first reported a position in Haemonetics in Q4 2014 and has held it in 20 quarters since.
  • Huntington National Bank's Haemonetics position peaked at $23K in Q2 2020.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.